Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-06-18

FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Venlafaxine hydrochloride from Aurobindo Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Venlafaxine hydrochloride (Venlafaxine hydrochloride)

Snippet

SUPPL AP for VENLAFAXINE (VENLAFAXINE HYDROCHLORIDE)